VC-backed Alcresta appoints CEO

Alcresta Therapeutics Inc, a developer of enzyme-based products, has named Daniel Orlando as CEO and a member of its board of directors. Prior to joining Alcresta, Orlando was chief operating officer at Vericel Corporation. Alcresta is backed by Athyrium Capital Management, Bessemer Venture Partners, HealthQuest Capital, Frazier Healthcare Partners and Third Rock Ventures.

PeopleNorth AmericaUSHealthcareBriefs